Log In
Print
BCIQ
Print
Print this Print this
 

JD-5037

  Manage Alerts
Collapse Summary General Information
Company Jenrin Discovery Inc.
DescriptionPeripheral cannabinoid CB1 receptor (CNR1) inverse agonist
Molecular Target Cannabinoid CB1 receptor (CNR1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today